FIA
APLS

FNY Investment Advisers’s Apellis Pharmaceuticals APLS Stock Holding History

FNY Investment Advisers’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25
Closed -$2K – 602
2023
Q2 		$2K Buy
+25
New +$2.16K ﹤0.01% 435

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's APLS Position: Q2 2026 in Review

FNY Investment Advisers sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 63,092 shares — an estimated $2.54M sold.

FNY Investment Advisers first reported a position in APLS in Q2 2021 and held it in 2 quarters. The position peaked at $2.54M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • FNY Investment Advisers reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 63,092 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.54M.
  • FNY Investment Advisers first reported a position in Apellis Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • FNY Investment Advisers's Apellis Pharmaceuticals position peaked at $2.54M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.